Published online
doi:10.1084/jem.20081752
The Journal of Experimental Medicine, Vol. 205, No. 13, 2965-2973
The Rockefeller University Press, 0022-1007 $30.00
© Gilfillan et al.
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan1,
Christopher J. Chan2,
Marina Cella1,
Nicole M. Haynes2,
Aaron S. Rapaport1,
Kent S. Boles1,
Daniel M. Andrews2,
Mark J. Smyth2, and
Marco Colonna1
1 Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110
2 Cancer Immunology Program, Sir Donald and Lady Trescowthick Laboratories, Peter MacCallum Cancer Centre, East Melbourne, 3002 Victoria, Australia
CORRESPONDENCE Marco Colonna: mcolonna{at}pathology.wustl.edu
Natural killer (NK) cells and CD8 T cells require adhesion molecules for migration, activation, expansion, differentiation, and effector functions. DNAX accessory molecule 1 (DNAM-1), an adhesion molecule belonging to the immunoglobulin superfamily, promotes many of these functions in vitro. However, because NK cells and CD8 T cells express multiple adhesion molecules, it is unclear whether DNAM-1 has a unique function or is effectively redundant in vivo. To address this question, we generated mice lacking DNAM-1 and evaluated DNAM-1–deficient CD8 T cell and NK cell function in vitro and in vivo. Our results demonstrate that CD8 T cells require DNAM-1 for co-stimulation when recognizing antigen presented by nonprofessional antigen-presenting cells; in contrast, DNAM-1 is dispensable when dendritic cells present the antigen. Similarly, NK cells require DNAM-1 for the elimination of tumor cells that are comparatively resistant to NK cell–mediated cytotoxicity caused by the paucity of other NK cell–activating ligands. We conclude that DNAM-1 serves to extend the range of target cells that can activate CD8 T cell and NK cells and, hence, may be essential for immunosurveillance against tumors and/or viruses that evade recognition by other activating or accessory molecules.
S. Gilfillan, C.J. Chan, M.J. Smyth, and M. Colonna contributed equally to this paper.
© 2008 Gilfillan et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Sondergaard, H., Coquet, J. M., Uldrich, A. P., McLaughlin, N., Godfrey, D. I., Sivakumar, P. V., Skak, K., Smyth, M. J.
(2009). Endogenous IL-21 Restricts CD8+ T Cell Expansion and Is not Required for Tumor Immunity. J. Immunol.
183: 7326-7336
[Abstract]
[Full Text]
-
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., Stern-Ginossar, N., Tsukerman, P., Jonjic, S., Mandelboim, O.
(2009). The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA
106: 17858-17863
[Abstract]
[Full Text]
-
Carlsten, M., Norell, H., Bryceson, Y. T., Poschke, I., Schedvins, K., Ljunggren, H.-G., Kiessling, R., Malmberg, K.-J.
(2009). Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells. J. Immunol.
183: 4921-4930
[Abstract]
[Full Text]
-
Seth, S., Georgoudaki, A.-M., Chambers, B. J., Qiu, Q., Kremmer, E., Maier, M. K., Czeloth, N., Ravens, I., Foerster, R., Bernhardt, G.
(2009). Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells. J. Leukoc. Biol.
86: 91-101
[Abstract]
[Full Text]